STING1 and neoplasm: Originally, 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a flavonoid with putative anti-tumour activity provided a proof-of-concept for the use of STING agonists to strengthen tumour immunity [20,61,62,63,64,65,66,67,68].